The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin - oral vinorelbine and radiotherapy (GFPC 08-06).
 
Hervé Le Caer
No Relationships to Disclose
 
Nicolas Pourel
No Relationships to Disclose
 
Henri Berard
No Relationships to Disclose
 
Jean-Bernard Auliac
No Relationships to Disclose
 
Isabelle Monnet
No Relationships to Disclose
 
Renaud Descourt
No Relationships to Disclose
 
Alain Vergnenegre
Honoraria - AstraZeneca; Boehringer Ingelheim; MSD; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Janssen; MSD; Pierre Fabre; Roche; Teva
 
Isabelle Martel Lafay
No Relationships to Disclose
 
Laurent Greillier
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Christos Chouaid
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Lilly; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Lilly; MSD; Novartis; Roche
 
Chrystele Locher
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Mundipharma; Novartis